La Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore è un policlinico universitario di Roma progettato da Giuseppe Cigni e Gaetano Minnucci, sede della facoltà di Medicina e Chirurgia dell'Università Cattolica del Sacro Cuore.

During the past decade, Policlinico Univ. A. Gemelli; Polo di Scienze Oncologiche ed Ematologiche conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Policlinico Univ. A. Gemelli; Polo di Scienze Oncologiche ed Ematologiche" are "Haemophilia A" (1 trials), "Leukemia, Lymphocytic, Chronic, B-Cell" (1 trials), "Moderate Hemophilia A" (1 trials), "Moderate Hereditary Factor VIII Deficiency Disease Without Inhibitor" (1 trials) and "Respiratory Syncytial Virus Infections" (1 trials). Many other conditions were trialed in "Policlinico Univ. A. Gemelli; Polo di Scienze Oncologiche ed Ematologiche" in a lesser frequency.

Most popular intervention types in "Policlinico Univ. A. Gemelli; Polo di Scienze Oncologiche ed Ematologiche" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Emicizumab" (1 trials), "Ibrutinib" (1 trials), "JNJ-53718678 125 mg" (1 trials), "JNJ-53718678 250 mg" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Policlinico Univ. A. Gemelli; Polo di Scienze Oncologiche ed Ematologiche" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Policlinico Univ. A. Gemelli; Polo di Scienze Oncologiche ed Ematologiche". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Policlinico Univ. A. Gemelli; Polo di Scienze Oncologiche ed Ematologiche, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Policlinico Univ. A. Gemelli; Polo di Scienze Oncologiche ed Ematologiche, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".